181 related articles for article (PubMed ID: 33853118)
1. Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.
Shyamasunder AH; Pai R; Ramamoorthy H; Sakhti D; Manipadam MT; Kapoor N; Paul TV; Jebasingh F; Thomas N; Abraham DT; Paul MJ; Chacko AG; Prabhu K; Rajaratnam S
Horm Metab Res; 2021 Apr; 53(4):245-256. PubMed ID: 33853118
[TBL] [Abstract][Full Text] [Related]
2. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
[TBL] [Abstract][Full Text] [Related]
4. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
Lindberg D; Akerström G; Westin G
Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
[TBL] [Abstract][Full Text] [Related]
7. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
9. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).
Turner JJ; Christie PT; Pearce SH; Turnpenny PD; Thakker RV
Hum Mutat; 2010 Jan; 31(1):E1089-101. PubMed ID: 19953642
[TBL] [Abstract][Full Text] [Related]
11. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.
Park JH; Kim IJ; Kang HC; Lee SH; Shin Y; Kim KH; Lim SB; Kang SB; Lee K; Kim SY; Lee MS; Lee MK; Park JH; Moon SD; Park JG
Clin Genet; 2003 Jul; 64(1):48-53. PubMed ID: 12791038
[TBL] [Abstract][Full Text] [Related]
14. Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
Chevalier B; Coppin L; Romanet P; Cuny T; Maïza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF
J Clin Endocrinol Metab; 2024 Jun; 109(7):e1482-e1493. PubMed ID: 38288531
[TBL] [Abstract][Full Text] [Related]
15. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S; Zhang CX; Serova-Sinilnikova O; Wautot V; Salandre J; Buisson N; Waterlot C; Bauters C; Porchet N; Aubert JP; Emy P; Cadiot G; Delemer B; Chabre O; Niccoli P; Leprat F; Duron F; Emperauger B; Cougard P; Goudet P; Sarfati E; Riou JP; Guichard S; Rodier M; Meyrier A; Caron P; Vantyghem MC; Assayag M; Peix JL; Pugeat M; Rohmer V; Vallotton M; Lenoir G; Gaudray P; Proye C; Conte-Devolx B; Chanson P; Shugart YY; Goldgar D; Murat A; Calender A
Am J Hum Genet; 1998 Aug; 63(2):455-67. PubMed ID: 9683585
[TBL] [Abstract][Full Text] [Related]
16. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
17. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
18. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.
Tham E; Grandell U; Lindgren E; Toss G; Skogseid B; Nordenskjöld M
J Clin Endocrinol Metab; 2007 Sep; 92(9):3389-95. PubMed ID: 17623761
[TBL] [Abstract][Full Text] [Related]
19. Novel germline mutations of the MEN1 gene in Greek families with multiple endocrine neoplasia type 1.
Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Koutsodontis G; Metaxa-Mariatou V; Economopoulos T; Raptis SA; Hadjidakis D
Clin Endocrinol (Oxf); 2009 Jan; 70(1):75-81. PubMed ID: 18549467
[TBL] [Abstract][Full Text] [Related]
20. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
